SCHEMBL16904074

SCHEMBL16904074

Cc1cc(S(=O)(=O)c2ccc(N=C=S)cc2)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.49
▸ CA2 P00918 2/20 0.49
▸ ALDH1A1 P00352 6/20 0.41
▸ MAPT P10636 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ USP2 O75604 2/20 0.41
▸ LTA P01374 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ P2RX3 P56373 2/20 0.41
▸ RAD51 Q06609 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ P2RY6 Q15077 2/20 0.38
▸ RAD1 O60671 1/20 0.38
▸ LMNA P02545 5/20 0.38
▸ BCL2 P10415 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ PTGS2 P35354 2/20 0.36
▸ CCR2 P41597 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29929894 0.80 PTGS2 (0.47) ALDH1A1MAPTCYP3A4TDP1LMNA
SCHEMBL483832 0.80 CA1 (0.70) CA1CA2ALDH1A1MAPTCYP3A4
SCHEMBL4362606 0.80 PTGS2 (0.47) ALDH1A1MAPTCYP3A4TDP1LMNA
SCHEMBL30543087 0.79 CA1 (0.45) CA1CA2ALDH1A1MAPTCYP3A4
SCHEMBL30543083 0.79 CA1 (0.45) CA1CA2ALDH1A1MAPTCYP3A4
SCHEMBL15563090 0.79 CA1 (0.45) CA1CA2ALDH1A1MAPTCYP3A4
SCHEMBL11574824 0.79 TDP1 (0.42) CA1CA2ALDH1A1MAPTCYP3A4
SCHEMBL25891586 0.78 CA1 (0.50) CA1CA2ALDH1A1MAPTCYP3A4
SCHEMBL13997435 0.77 GAA (0.61) CA2ALDH1A1MAPTCYP3A4HPGD
SCHEMBL25891612 0.77 LMNA (0.40) ALDH1A1MAPTKDM4EUSP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708338-B2 Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof NEUROPORE THERAPIES, INC. (US) 2023-07-25 — — US disclosed
US-20150197513-A1 ARYL- AND HETEROARYL-SUBSTITUTED BENZENE DERIVATIVES AS MODULATORS OF PI3-KINASE SIGNALLING PATHWAYS NEUROPORE THERAPIES, INC. 2015-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708338-B2 Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof TPMT, ABCB1, DPP8 CA1 4486/4885CA2 3591/4885ALDH1A1 1945/4885
US-20150197513-A1 ARYL- AND HETEROARYL-SUBSTITUTED BENZENE DERIVATIVES AS MODULATORS OF PI3-KINASE SIGNALLING PATHWAYS TFEB, ULK1, MTOR CA1 4869/4885CA2 4301/4885ALDH1A1 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback